These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
76 related items for PubMed ID: 3875671
1. Inhibitors of plasma thromboplastin antecedent (factor XI): studies on mechanism of inhibition. Goldsmith GH, Silverman P. J Lab Clin Med; 1985 Sep; 106(3):279-85. PubMed ID: 3875671 [Abstract] [Full Text] [Related]
2. Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin. Saito H, Ratnoff OD, Marshall JS, Pensky J. J Clin Invest; 1973 Apr; 52(4):850-61. PubMed ID: 4266422 [Abstract] [Full Text] [Related]
3. Studies on plasma thromboplastin antecedent (factor XI), PTA deficiency and inhibition of PTA by plasma: pharmacologic inhibitors and specific antiserum. Forbes CD, Ratnoff OD. J Lab Clin Med; 1972 Jan; 79(1):113-27. PubMed ID: 4257309 [No Abstract] [Full Text] [Related]
7. Plasma thromboplastin antecedent (PTA, factor XI): a specific and sensitive radioimmunoassay. Saito H, Goldsmith GH. Blood; 1977 Sep; 50(3):377-85. PubMed ID: 884316 [Abstract] [Full Text] [Related]
8. Studies on a circulating anticoagulant inhibiting factor XI in a patient with congenital deficiency and carcinoma of the prostate. Chediak J, Madej-Zevin P, Ratnoff OD, Goldsmith GH, Everson B. Br J Haematol; 1986 May; 63(1):123-33. PubMed ID: 3486671 [Abstract] [Full Text] [Related]
10. A simple and accurate microplate assay for the determination of factor XI in plasma. Scott CF, Colman RW. J Lab Clin Med; 1988 Jun; 111(6):708-14. PubMed ID: 3373114 [Abstract] [Full Text] [Related]
11. Surface adsorption of factor XI. II. Evidence that different mechanisms are involved in binding to glass and plastic materials. Mannhalter C, Schiffman S. Thromb Haemost; 1982 Jun 28; 47(3):214-7. PubMed ID: 6981227 [Abstract] [Full Text] [Related]
12. Hemostatic defect due to acquired circulating inhibitors against lipid procoagulant and factor VIII. Pechet L, Snyder LM, Chesney C, Colman RW. Thromb Diath Haemorrh; 1974 Sep 30; 32(1):90-104. PubMed ID: 4548947 [Abstract] [Full Text] [Related]
13. Studies on a circulating anticoagulant in systemic lupus erythematosus: evidence for inhibition of the function of activated plasma thromboplastin antecedent (factor XIa). Krieger H, Leddy JP, Breckenridge RT. Blood; 1975 Aug 30; 46(2):189-97. PubMed ID: 237589 [Abstract] [Full Text] [Related]
14. Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants. Lin J, Deng H, Jin L, Pandey P, Quinn J, Cantin S, Rynkiewicz MJ, Gorga JC, Bibbins F, Celatka CA, Nagafuji P, Bannister TD, Meyers HV, Babine RE, Hayward NJ, Weaver D, Benjamin H, Stassen F, Abdel-Meguid SS, Strickler JE. J Med Chem; 2006 Dec 28; 49(26):7781-91. PubMed ID: 17181160 [Abstract] [Full Text] [Related]
15. Contact-activated fibrinolysis: role of surface concentration and high-molecular-weight kininogen. Goldsmith GH. J Lab Clin Med; 1980 Aug 28; 96(2):222-31. PubMed ID: 7400661 [Abstract] [Full Text] [Related]
17. In vitro anticoagulation monitoring of low-molecular-weight heparin. Wang JQ, Shi XB, Yang JG, Hu DY. Chin Med J (Engl); 2009 May 20; 122(10):1199-202. PubMed ID: 19493471 [Abstract] [Full Text] [Related]
18. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies. Galli M, Beretta G, Daldossi M, Bevers EM, Barbui T. Thromb Haemost; 1997 Mar 20; 77(3):486-91. PubMed ID: 9065999 [Abstract] [Full Text] [Related]